Rabies Diagnostics Market to Surpass USD 2.15 Billion by 2034

Pune, India, November 2025 - The latest report from Exactitude Consultancy reveals that the Global Rabies Diagnostics Market is valued at USD 1.26 billion in 2024 and is expected to reach USD 2.15 billion by 2034, expanding at a CAGR of 5.3% between 2025 and 2034. The market is driven by increasing rabies surveillance programs, enhanced diagnostic capabilities, and global efforts to achieve the "Zero Human Deaths by 2030" initiative.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49076

Key Takeaways
• Market Size (2024): USD 1.26 Billion
• Forecast (2034): USD 2.15 Billion
• CAGR (2025-2034): 5.3%
• Primary Growth Drivers: Expansion of veterinary diagnostics, improved laboratory infrastructure, and government-led eradication programs.
• Top Companies: Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, Qiagen, and Creative Diagnostics.
• Key End Users: Diagnostic Laboratories, Hospitals, Public Health Agencies, and Veterinary Clinics.

Market Story
Rabies remains a global public health concern, claiming thousands of lives annually, predominantly in Asia and Africa. Diagnostic testing plays a crucial role in early detection, post-exposure management, and surveillance of rabies among humans and animals.
The market is witnessing a rapid shift from conventional microscopic techniques to advanced molecular and immunodiagnostic assays such as ELISA, PCR, and rapid antigen tests.

Technological advancements, such as AI-powered image recognition, automated detection kits, and portable PCR devices, are enhancing accessibility and reliability, particularly in resource-limited regions. Moreover, collaborative programs by organizations like WHO, OIE, and FAO are accelerating diagnostic adoption to support global elimination goals.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49076/rabies-diagnostics-market

Market Segmentation
By Diagnostic Technique:
• Fluorescent Antibody Test (FAT)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR)
• Rapid Antigen Detection
• Others

By End User:
• Hospitals & Clinics
• Diagnostic Laboratories
• Veterinary Centers
• Public Health Institutes

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: Thermo Fisher Scientific launched a portable PCR-based rabies detection system for field testing in remote areas.
• 2024: Bio-Rad Laboratories introduced a next-generation ELISA kit for simultaneous animal and human rabies surveillance.
• 2024: Merck KGaA collaborated with global veterinary agencies to provide affordable diagnostic reagents in developing countries.
• 2023: Qiagen expanded its molecular diagnostics portfolio to include optimized rabies RNA detection assays.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49076

Expert Insight
"The rising emphasis on zoonotic disease control and one-health initiatives is reshaping how countries approach rabies diagnostics," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Advanced molecular techniques and rapid testing solutions are closing the gap between detection and response, bringing the global health community closer to zero rabies deaths."

Regional Outlook
• North America leads the market with well-established laboratory systems, advanced technology, and strong government funding for zoonotic disease surveillance.
• Europe maintains a steady growth pace through cross-border animal monitoring and public health partnerships.
• Asia Pacific exhibits the fastest growth, projected at 6.8% CAGR, driven by large-scale vaccination programs and increasing diagnostic infrastructure in India, China, and Southeast Asia.
• Latin America & Africa are focusing on decentralized testing and affordable rapid kits to manage rural outbreaks.

Conclusion
The Rabies Diagnostics Market is advancing toward a more connected, technology-driven ecosystem where accessibility, speed, and accuracy define success. The combined efforts of public health authorities, veterinary organizations, and diagnostic manufacturers are expected to significantly strengthen global rabies control strategies by 2034.

This report is also available in the following languages : Japanese (狂犬病診断), Korean (광견병 진단), Chinese (狂犬病诊断), French (Diagnostic de la rage), German (Tollwutdiagnostik), and Italian (Diagnostica della rabbia), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49076

Our More Reports:

Endodontic Devices Market
https://exactitudeconsultancy.com/reports/49081/endodontic-devices-market

Hepatitis B Treatment Market
https://exactitudeconsultancy.com/reports/49083/hepatitis-b-treatment-market

Surgical Site Infection Control Market
https://exactitudeconsultancy.com/reports/49085/surgical-site-infection-control-market

Biliary Catheters Market
https://exactitudeconsultancy.com/reports/49087/biliary-catheters-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.